CVS Caremark among recipients of NACD New England 2013 Director of the Year Awards
BOSTON — CVS Caremark was named Public Company Board of the Year in the National Association of Corporate Directors New England Chapter’s Seventh Annual 2013 Director of the Year Awards.
NACDNE is a source in New England for corporate governance information, education and training for directors and CEOs who are committed to raising standards and improving boardroom performance. Each year, NACDNE recognizes board members and boards from public, private and nonprofit organizations who exemplify the key attributes of outstanding directors.
NACDNE will present the awards to the recipients at a formal recognition ceremony on April 11 at the Renaissance Boston Waterfront Hotel.
“NACDNE’s Director of the Year Awards honor those who uphold the highest professional standards for corporate governance,” stated R. Robert Popeo, president of NACDNE and chairman and president of Mintz Levin. “On the heels of the greatest financial meltdown in modern day history and the resulting sweeping regulatory reforms, such as the Dodd-Frank Act, this is a demanding environment for corporate boards. It is more important than ever to recognize effective boardroom leaders who guide companies through challenging times by making tough decisions with foresight and integrity.”
This year, NACDNE recognized three individual board members and two boards. More than 40 New England directors worked collaboratively to determine the slate of honorees.
“CVS Caremark’s board of directors plays a pivotal role in helping our company fulfill its purpose of putting people on their path to better health,” stated Larry Merlo, president and CEO of CVS Caremark. “Thanks in part to the leadership and guidance of our board, we are bringing forward innovative healthcare solutions that increase access to care, lower overall healthcare costs and result in positive health outcomes. We are pleased that this award recognizes our board’s significant ongoing efforts to improve and enhance pharmacy care.”
Crossmark names Joe Crafton CEO
PLANO, Texas — Crossmark, a sales and marketing services company in the consumer goods industry, has announced several executive moves, including the appointment of Joe Crafton as CEO. He previously served as company president.
John Thompson, Crossmark’s CEO since 2010, now will focus primarily on acquisitions and strategic alliances as the company’s chief strategy officer. Thompson remains a shareholder, serves on the board, and will continue to be responsible for overseeing the company’s international businesses.
Ben Fischer maintains his role as COO and has assumed the additional title of president as well as other responsibilities.
The moves, which were effective Jan. 7, come after the recent majority investment in Crossmark by an affiliate of Warburg Pincus, which, according to Thompson, brings a renewed focus on growth.
“We have charted a course for the future that positions us well to grow our business and better serve our clients,” Thompson stated. “I chose to create the new chief strategy officer role in order to better focus my efforts on external growth opportunities. Simultaneously, Joe and Ben will continue to develop and lead new initiatives that will continue to enhance service to our clients and customers.”
Crafton began his Crossmark career in 1988, was elected to the board in 2000 and held a variety of leadership positions before being appointed president of the company in 2010. Prior to joining the company, Crafton was a manager with Procter & Gamble.
“For nearly 25 years, Joe has proven himself in a variety of Crossmark senior leadership roles in both the legacy sales agency business as well as emerging and innovative service businesses,” added Jim Neary, managing director of Warburg Pincus. “Under Joe’s leadership of the company’s marketing services division, Crossmark has become the North American leader of in-store marketing services.”
“We have great people and a strong culture of exceeding clients’ expectations with service excellence. With the twin tailwinds of both outsourcing and shopper marketing, we are well positioned for significant growth. I look forward to building on our company’s strong foundation and to continue delivering more value and growth for our clients and customers,” Crafton stated.
As U.S. health system lags other nations, need grows for larger role for pharmacists
Opponents of health reform are usually quick to make comparisons between our nation’s healthcare system and that of the rest of the world. Americans, they argue, enjoy the most advanced and most effective health care in the world. And forcing the U.S. system to change – either through new, evidence-based government payment incentives, federally mandated quality and cost controls, or through new methods for delivering primary care or making health decisions on behalf of patients – would only jeopardize the patient-doctor relationship and undermine the best healthcare network in the world.
Those opponents of change are wrong, in part because they’re willing to accept the status quo for U.S. health care, which is unsustainable for the simple reason that the nation can’t afford the current fee-for-service health system and its skyrocketing costs. But they’re also wrong because they’re proceeding from a flawed assumption: that our health system is tops among all nations.
A new report from the non-profit National Academies, the National Institutes of Health and the Department of Health and Human Services smacks that argument “upside the head,” as we say in the South. Based on a major comparison study of many health markers in 17 developed countries including the U.S., Canada, Australia, Japan and western European nations, the report “gives low marks to the United States in the health of its citizens, finding that Americans have higher rates of injury and disease and die sooner than their counterparts in other developed countries,” writes DSN associate editor Alaric DeArment.
The U.S., he reports, ranks “at or near the bottom in terms of infant mortality and low birth weight, injuries and homicides, teenage pregnancies and sexually transmitted infections, prevalence of HIV and AIDS, drug-related deaths, obesity and diabetes, heart disease, chronic lung disease and disability.” Equally striking, we’ve had “the highest infant mortality rate of any high-income country for decades while also ranking poorly in premature birth and the proportion of children who live to age 5 years.”
“What concerns our panel is why, for decades, we have been slipping behind,” says the report’s lead author, Virginia Commonwealth University professor of family medicine Steven Woolf.
If ever there was a time when the nation’s health care system was ripe for big change – including a larger role for pharmacists as disease managers, front-line patient care team members and wellness advocates – that time is now.